Description
-
Dr. Paul Langlois – Pharmacology of Infectious Diseases and Immunizations
- Faculty:
- Dr. Paul Langlois
- Duration:
- 5 Hours 45 Minutes
- Format:
- Audio and Video
- Copyright:
- Oct 17, 2017
Description
- Antimicrobials
- Preventive strategies to limit antimicrobial resistance
- C. Difficile
- UTIs
- Respiratory Infections
- Skin Infections
- Treatment (IDSA) guidelines
- Immunizations (Adult)
Attend this seminar and learn proper prescribing, patient education and monitoring procedures for a variety of drug regimens used to treat common acute and chronic infectious diseases. Choosing an antibacterial agent can be challenging, given the plethora of drugs available on the market and the emerging trend in bacterial resistance.
You will learn the pharmacology of different classes of antimicrobials used to treat infectious disease states encountered in clinical practice. Discover the spectrums of activity, pharmacokinetic characteristics and parameters for monitoring therapeutic outcomes. Emphasis is placed on the new antimicrobials and advances in evidence-based treatment guidelines. You will leave this seminar better prepared to design appropriate and cost-effective drug regimens for improved therapeutic outcomes.
Handouts
| Manual ZNM075125 (7.34 MB) | 79 Pages | Available after Purchase |
Outline
Bacterial Characteristics
- Cell envelope characteristics
- Gram stain procedures
- Gram positive & Gram negative organisms
Antibiotic Prescribing Background
- Interpreting culture & sensitivity
- Inhibitory concentration vs. bactericidal concentration
- Empiric vs. targeted therapy
- Antibiogram
Medication Allergy vs. Adverse Effect
- Defining true allergic response
- PCN-Carbapenem cross reactivity
Antibiotic Resistance
- MRSA
- VRE
- Extended Spectrum Beta-Lactamases
- Klebsiella Pneumoniae
- Carbapenemase
Drug Resistant Threats in the U.S.
- C. Diff
- CRE
- Neisseria Gonorrhea
- Tuberculosis
Current CDC Guidelines
- Antibiotic stewardship
- Start and stop recommendations
NEW Antibiotics for 2017
- Signs & symptoms
- Causative organisms
- Pharmacologic management
- Non-pharmacologic management for:
- Pneumonia
- Bronchitis
- Sinusitis
- Pharyngitis
- Acute Cystitis
- Catheter-related UTIs
- Pelvic Inflammatory Disease
- Brain Abscess
- Meningitis
- Cellulitis
- Diabetic Foot Ulcers
- Osteomyelitis
- Influenza
- Human & Animal bites
Common Effects of Antibiotics on Other Medications
- Cardiac medications
- Anti-seizure medications
- Anticoagulants
- Antifungal agents
Bioterrorism: Diagnosis & Treatment
- Bacillus anthracis
- Clostridium botulinum
- Yersinia pestis
- Francisella tularensis
CDC Immunization Schedule for Adults
- Types of vaccines
- Indications & Contraindications
Faculty
Dr. Paul Langlois, APN, Ph.D., CCRN, CCNS, CNRN Related seminars and products: 21
Dr. Paul Langlois, APN, Ph.D., CCRN, CCNS, CNRN, is a critical care clinical specialist in the Surgical, Medical, Neurologic, Burn, CCU and Trauma ICUs of Cook County Hospital, Chicago. Drawing on over 30 years of experience assessing and managing patients with life-threatening diseases, Dr. Langlois provides advanced-level training to nurses, physician assistants, nurse practitioners and physicians. Dr. Langlois received his Doctor of Nursing degree from Rush University in Chicago, Illinois.
Dr. Langlois is committed to providing the highest quality of care to patients through advanced education. His presentations are evidence-based, timely and provide participants with case studies to facilitate critical thinking. As a bedside clinical nurse specialist, he has developed several institution-wide protocols for the multidisciplinary assessment and management of the cardiac, neurologic, septic, and multi-system organ failure patient.
His presentations are enthusiastically delivered and offer practical tips that help make the most challenging concepts easy to understand. Linking knowledge to clinical practice is the goal of every educational program.
Speaker Disclosures:
Financial: Paul Langlois has an employment relationship with Cook County Hospital. He receives a speaking honorarium from PESI, Inc.
Non-financial: Paul Langlois has no relevant non-financial relationship to disclose.
Reviews
There are no reviews yet.